Your browser doesn't support javascript.
loading
Tumor Growth Rate to Predict the Outcome of Patients with Neuroendocrine Tumors: Performance and Sources of Variability.
Dromain, Clarisse; Sundin, Anders; Najran, Pavan; Vidal Trueba, Hector; Dioguardi Burgio, Marco; Crona, Joakim; Opalinska, Marta; Carvalho, Luciana; Franca, Regis; Borg, Philip; Vietti Violi, Naik; Schaefer, Niklaus; Lopez, Carlos; Pezzutti, Daniela; de Mestier, Louis; Lamarca, Angela; Costa, Frederico; Pavel, Marianne; Ronot, Maxime.
Afiliação
  • Dromain C; Department of Radiology, CHUV University Hospital, UNIL University of Lausanne, Lausanne, Switzerland.
  • Sundin A; Department of Radiology, Institution of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Najran P; Department of Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Vidal Trueba H; Department of Radiology, Hospital Universitario Marques de Valdecilla, Santander, Spain.
  • Dioguardi Burgio M; Department of Radiology, Beaujon University Hospital, Clichy, France.
  • Crona J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Opalinska M; Nuclear Medicine Unit, Department of Endocrinology, University Hospital, Krakow, Poland.
  • Carvalho L; Department of Radiology, Sirio-Libanes Hospital, Sao Paulo, Brazil.
  • Franca R; Department of Radiology, Sirio-Libanes Hospital, Sao Paulo, Brazil.
  • Borg P; Department of Radiology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
  • Vietti Violi N; Department of Radiology, CHUV University Hospital, UNIL University of Lausanne, Lausanne, Switzerland.
  • Schaefer N; Department of Radiology, CHUV University Hospital, UNIL University of Lausanne, Lausanne, Switzerland.
  • Lopez C; Department of Oncology, Hospital Universitario Marques de Valdecilla, Santander, Spain.
  • Pezzutti D; Department of Radiology, Israelita Albert Einstein Hospital, Sao Paulo, Brazil.
  • de Mestier L; Department of Oncology, Beaujon University Hospital, Clichy, France.
  • Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.
  • Costa F; Department of Medical Oncology, Sirio-Libanes Hospital, Sao Paulo, Brazil.
  • Pavel M; Department of Endocrinology, Universitatsklinikum Erlangen, Erlangen, Germany.
  • Ronot M; Department of Radiology, Beaujon University Hospital, Clichy, France, maxime.ronot@aphp.fr.
Neuroendocrinology ; 111(9): 831-839, 2021.
Article em En | MEDLINE | ID: mdl-32717738
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Tumores Neuroendócrinos / Carga Tumoral / Intervalo Livre de Progressão Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Tumores Neuroendócrinos / Carga Tumoral / Intervalo Livre de Progressão Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article